Search results
Results from the WOW.Com Content Network
The Medical Marijuana and Cannabidiol Research Expansion Act is an Act of Congress allowing medical research on cannabis. The act is "the first standalone marijuana-related bill approved by both chambers of the United States Congress".
Marijuana has a lower potential for abuse than other drugs that are subjected to the same restrictions, with some scientific support for its use as a medical treatment, researchers from the US ...
The Drug Enforcement Administration initiated a 2024 policy review to potentially reschedule marijuana as a Schedule III drug, amounting to "the agency's biggest policy change in more than 50 years". [4] Some hiring and retention policies in federal employment and the armed forces evolved during 2024.
The stated mission of NIDA is to support research on the causes, consequences, prevention, and treatment of drug abuse and drug addiction, and not the medicinal uses of drugs. [93] Consequently, many studies on the therapeutic benefits of cannabis were either denied or altered to comply with the limited scope and mission of NIDA. [86]
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]
The DEA publication Exposing the Myth of Smoked Medical Marijuana interpreted the IOM's statement, "While we see a future in the development of chemically defined cannabinoid drugs, we see little future in smoked marijuana as a medicine," as meaning that smoking cannabis is not recommended for the treatment of any disease condition. [52]
President Biden on Thursday announced mass pardons for federal marijuana possession, a step long sought by advocates and the most significant action on marijuana his administration has taken to date.
Was the Department of Health Division of Medical Marijuana and Integrative Therapy until October 1, 2020; [6] medical cannabis only – there is no regulatory agency for other use. [a] Puerto Rico Medical Cannabis Regulatory Board (a division of the Puerto Rico Department of Health). The Board was created in 2017 under the MEDICINAL Act of 2017 ...